CXCL8 and arthritic joint disease: Animal experiments demonstrated that KXC downregulated the expression of IL-8 and γIP-10 mRNA, reduced synovial inflammation, alleviated the formation of pannus, decreased joint damage and fibrous tissue proliferation, and promoted tissue repair in the synovium of rats with collagen induced arthritis [38–40].